title: Identification of targets of leptin action in rat hypothalamus.
abstract: The hypothesis that leptin (OB protein) acts in the hypothalamus to reduce food intake and body weight is based primarily on evidence from leptin-deficient, ob/ob mice. To investigate whether leptin exerts similar effects in normal animals, we administered leptin intracerebroventricularly (icv) to Long-Evans rats. Leptin administration (3.5 microg icv) at the onset of nocturnal feeding reduced food intake by 50% at 1 h and by 42% at 4 h, as compared with vehicle-treated controls (both P < 0.05). To investigate the basis for this effect, we used in situ hybridization (ISH) to determine whether leptin alters expression of hypothalamic neuropeptides involved in energy homeostasis. Two injections of leptin (3.5 microg icv) during a 40 h fast significantly decreased levels of mRNA for neuropeptide Y (NPY, which stimulates food intake) in the arcuate nucleus (-24%) and increased levels of mRNA for corticotrophin releasing hormone (CRH, an inhibitor of food intake) in the paraventricular nucleus (by 38%) (both P < 0.05 vs. vehicle-treated controls). To investigate the anatomic basis for these effects, we measured leptin receptor gene expression in rat brain by ISH using a probe complementary to mRNA for all leptin receptor splice variants. Leptin receptor mRNA was densely concentrated in the arcuate nucleus, with lower levels present in the ventromedial and dorsomedial hypothalamic nuclei and other brain areas involved in energy balance. These findings suggest that leptin action in rat hypothalamus involves altered expression of key neuropeptide genes, and implicate leptin in the hypothalamic response to fasting.
authors.affiliation: Department of Medicine, University of Washington, Seattle 98108, USA.
authors.forename: M W
authors.initials: MW
authors.lastname: Schwartz
authors.forename: R J
authors.initials: RJ
authors.lastname: Seeley
authors.forename: L A
authors.initials: LA
authors.lastname: Campfield
authors.forename: P
authors.initials: P
authors.lastname: Burn
authors.forename: D G
authors.initials: DG
authors.lastname: Baskin
mesh_terms: D000818:Animals; D001786:Blood Glucose / Q000032:analysis; D002352:Carrier Proteins / Q000235:genetics / Q000302:isolation & purification; D003345:Corticosterone / Q000097:blood; D003346:Corticotropin-Releasing Hormone / Q000235:genetics / Q000378:metabolism*; D004435:Eating / Q000187:drug effects*; D005215:Fasting / Q000502:physiology; D005786:Gene Expression Regulation / Q000187:drug effects*; D007031:Hypothalamus / Q000033:anatomy & histology / Q000187:drug effects* / Q000378:metabolism; D017403:In Situ Hybridization; D007276:Injections, Intraventricular; D007328:Insulin / Q000097:blood; D020738:Leptin; D008297:Male; D009478:Neuropeptide Y / Q000235:genetics / Q000378:metabolism*; D011506:Proteins / Q000494:pharmacology*; D012333:RNA, Messenger / Q000302:isolation & purification; D051381:Rats; D011919:Rats, Inbred Strains; D011956:Receptors, Cell Surface; D054411:Receptors, Leptin; D014018:Tissue Distribution
chemical_list: D001786:Blood Glucose; D002352:Carrier Proteins; D007328:Insulin; D020738:Leptin; D009478:Neuropeptide Y; D011506:Proteins; D012333:RNA, Messenger; D011956:Receptors, Cell Surface; D054411:Receptors, Leptin; D003346:Corticotropin-Releasing Hormone; D003345:Corticosterone